|
Volumn 31, Issue 4, 2013, Pages 267-268
|
Mouse platforms jostle for slice of humanized antibody market.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
ANIMAL;
DRUG INDUSTRY;
ECONOMICS;
GENETIC ENGINEERING;
HUMAN;
LEGAL ASPECT;
MARKETING;
MOUSE;
NOTE;
PATENT;
TRANSGENIC MOUSE;
ANIMALS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DRUG INDUSTRY;
GENETIC ENGINEERING;
HUMANS;
INTELLECTUAL PROPERTY;
MARKETING;
MICE;
MICE, TRANSGENIC;
|
EID: 84884227602
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0413-267 Document Type: Note |
Times cited : (6)
|
References (0)
|